Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials

Authors:

Abstract
The systemic immune-inflammation index (SII) is a hematological marker that reflects the immune status of the body. This study was designed to evaluate the
Funding Information
  • the Cutting-edge Cancer Support Treatment Research Project (CPHCF-2023-023)
  • Scientific Research Project of Hunan Provincial Health Commission (D202302066995)
  • the Changsha Natural Science Foundation project (kq2007058)
  • Beijing Medical Award Foundation-China Endocrine Targeted Therapy Research Fund for Advanced breast cancer (YXJL-2020-0941-0747)

This publication has 29 references indexed in Scilit: